Jay Pandit

Director of Digital Medicine, Scripps Research, NU Cardiology, Physician Entrepreneur, Cancer Survivor, Story Banker and Life Long Learner. Views are my own.

[Jay Pandit @JayPandit]

The FDA isn’t issuing one-off wearable clearances any more - it’s building a regulatory architecture for continuous diagnostic surveillance. Cardiac, metabolic, neurodx, and RPM all moving in parallel. Medicine needs to catch up fast. #DigitalHealth #FDAclearance #ClinicalAI

[Jay Pandit @JayPandit]

Can a weight loss and diabetes drug treat long COVID? – San Diego Union-Tribune https://t.co/odz3gs0p2a

[Eric Topol @EricTopol]

Our @NatureMedicine paper on glucose spikes (CGM sensor) and their relationship with physical activity, gut microbiome, genomics, food intake, and sleep via multimodal A.I. Helps identify people with prediabetes who have high risk of progression (cf HbA1c)
https://t.co/5bWHXuOfTC
@GiorgioQuer @ScrippsRTI @scrippsresearch @segal_eran @JayPandit

[Andrew J Sauer MD @AndrewJSauer]

SCALE-HF Study Results just published in most recent @JCardFail issue! Work led by my friends @FudimMarat and Adam DeVore at @DCRINews but involving multiple centers.
1/🧵

https://t.co/NTeYhGhPRx

[Eric Topol @EricTopol]

The hospital-at-home movement is in its early days. Lots of potential using multimodal #AI remote monitoring and validation via randomized trials
https://t.co/zTwIdaAs0b by @FenitN w/ @JayPandit
https://t.co/7twOSjpErE

[npj Digital Medicine @npjDigitalMed]

This study from @ScrippsRTI examined wearable data like step count, resting heart rate, & sleep to track changes in people with + without #LongCovid over a year.

Those with Long #Covid_19 had significantly different resting heart rate & activity levels. They were also more likely to be women, younger, unvaccinated, & report more acute-phase symptoms.

https://t.co/9FyaFfQd8k

[SciStories LLC @TeamSciStories]

🎙️ Just listened to an enlightening podcast with @JayPandit on how biosensors are revolutionizing medicine! 🩺✨ Discover how these tiny devices are transforming diagnostics and patient care. #Biosensors #HealthcareInnovation
https://t.co/UTCPAjLscy

[Josh Cheema, MD, MSCI, MSAI @JCheemaMD]

Now out in JACC Advances, our viewpoint on AI within HF and how the future may look with the help of multimodality large language models @JayPandit

https://t.co/CzrsM2hSMU

[Jay Pandit @JayPandit]

@KevinDeBruyne You are a legend!! My kids are 8 and 3 and San Diego is the absolute best place to raise kids with amazing weather all year round!! With the weather you get oceans, mountains, beaches and snow!! Think about it!!

[Jay Pandit @JayPandit]

Acute care at home has all the ingredients to improve health care outcomes and costs and is the ideal place to test the impact of multimodal inpatient and outpatient health data streams. Let’s do the trials to show this!

https://t.co/zkZbtP0arg

[Eric Topol @EricTopol]

The hospital-at-home in the era of multimodal #AI
Our new review @Nature_NPJ of the prospects
by @JayPandit @ScrippsRTI @scrippsresearch and collaborators
https://t.co/7twOSjqchc

[Scripps Research @scrippsresearch]

Preliminary work by @ScrippsRTI & @eMedCertified show unexpectedly high proportion of COVID-19 rebound cases in untreated people, and those treated with Paxlovid. @JayPandit & the team now hope to assess the role of variants and the immune system response https://t.co/j8WHkdxQv3

[Eric Topol @EricTopol]

Just published
A prospective, systematic assessment of rebound after Paxlovid vs Covid untreated controls
https://t.co/OnfWsvub6L @JayPandit @michaelmina_lab
Viral rebound
Paxlovid 14.2% | Controls 9.3%
Symptom rebound
Paxlovid 18.9% | Controls 7.0%

[Jay Pandit @JayPandit]

@calimagna @evidation @Sagebio Congratulations Luca, a celebration is in order!

[Jay Pandit @JayPandit]

RIP Pele!! To the King, who made millions fall in love with Joga Bonito!! #Pele #JogaBonito

[Jay Pandit @JayPandit]

First report of our prospective paxlovid rebound study showing rebound of Covid sx more than previously reported, in both treated and untreated cohorts. More studies needed to understand this peculiar phenomenon, to clear myths causing underprescription.

[Eric Topol @EricTopol]

Our prospective Paxlovid rebound study with controls preprint is posted
By symptoms: ~12% rebound (19% Pax vs 7% controls)
By positive testing: ~5% rebound (14% Pax vs 9% controls)
Much lower than many estimates
https://t.co/czeGEYIJvA by @JayPandit @michaelmina_lab @ScrippsRTI

[Jay Pandit @JayPandit]

Heard this quote again today and had to share. “Science is not truth. Science is finding the truth. When science changes its opinion, it didn't lie to you. It learned more.” - Mohamed Safa. #science @scrippsresearch @ScrippsDTC

[Jay Pandit @JayPandit]

Digital health tools like smartphone apps and wearables are here to stay. We hope our work sheds light on the promises and challenges of their power to serve as supplementary population health tools. @ScrippsDTC @scrippsresearch @NUFeinbergMed

[Eric Topol @EricTopol]

Just published @NatureBiotech
Our review of smartphone apps for Covid-19: outbreak epidemiology, individual screening, contact tracing and their future
by @JayPandit @jmradin @GiorgioQuer @ScrippsRTI @scrippsresearch
https://t.co/NswHMmNmRl

[Jay Pandit @JayPandit]

Thank you for letting me continue to share my story.

“An individual has not started living until he/she can rise above the narrow confines of individualistic concerns to the broader concerns of all humanity” - MLK Jr

The Farewell https://t.co/e6bp4BYdp0 via @JAMA_current

[Jay Pandit @JayPandit]

RIP Dr. Farmer. Thank you for constantly reminding us that we are part of the human tribe.

[Partners In Health @PIH]

Partners In Health announced that its founder, Dr. Paul Farmer, unexpectedly passed away today in his sleep while in Rwanda.

Dr. Farmer was 62 years old. He is survived by his wife, Didi Bertrand Farmer, and their three children.

1/🧵